CN Stock MarketDetailed Quotes

688266 Suzhou Zelgen Biopharmaceuticals

Watchlist
  • 64.02
  • -3.53-5.23%
Market Closed Oct 11 15:00 CST
16.95BMarket Cap-73417P/E (TTM)

Suzhou Zelgen Biopharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Suzhou Zelgen Biopharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 1.219B--
--2024/FY-- / 623.565M--
--2023/FY386.439M / 429.000M--
--2021/FY190.361M / 208.000M--
--2020/FY27.661M / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 1.219B--
--2024/FY-- / 623.565M--
--2023/FY386.439M / 429.000M--
--2021/FY190.361M / 208.000M--
--2020/FY27.661M / 0.000--

Unlock Free Earnings Estimates

Suzhou Zelgen Biopharmaceuticals Earnings Reports

  • ZeJing Pharmaceutical's 2024 interim report

    Aug 23 12:00 ET

  • Summary of Zejing Pharmaceuticals' semi-annual report for 2024

    Aug 23 12:00 ET

  • Zejing Pharmaceutical 2023 Annual Report

    Apr 19 12:00 ET

  • Summary of Zejing Pharmaceutical's 2023 Annual Report

    Apr 19 12:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Oct 12, 2024

    Strong Buy

    • Strong Buy

      88.89%

    • Buy

      11.11%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    % Chg

    No Data